Transcatheter Thrombus Removal With the Penumbra Indigo Lightning System in Children With Congenital Heart Disease
- 18 November 2026
- journal article
- Published by Wiley in Catheterization and Cardiovascular Interventions
Abstract
Thromboembolic complications in children with congenital heart disease (CHD) carry significant morbidity and mortality, particularly in patients with single ventricle physiology. Current management strategies, including systemic anticoagulation, thrombolytics, and surgical thrombectomy, each carry substantial risks in this population. Transcatheter aspiration thrombectomy represents an emerging alternative. We retrospectively reviewed all pediatric patients with CHD at our institution who underwent transcatheter aspiration thrombectomy using the Penumbra Indigo Lightning System between January 2024 and February 2025. Patient demographics, cardiac diagnosis, thrombus location, procedural details, and clinical outcomes were recorded. Five patients (age 5 months to 9 years; weight 6.3–25.9 kg) with diverse CHD diagnoses underwent six thrombectomy procedures. Thrombus locations included the Fontan circuit, inferior vena cava, pulmonary arteries, and internal jugular veins. Technical success with angiographic restoration of antegrade flow and no residual gradient across the segment of interest, was achieved in all cases (100%). Blood loss ranged from 6 to 23 mL/kg; all patients required packed red blood cell transfusion. No significant intraprocedural hemodynamic instability occurred. Three patients were discharged home with confirmed vessel patency on follow‐up imaging (echocardiography and/or vascular ultrasound at 4–6 months post intervention). Two patients, both on extracorporeal membrane oxygenation (ECMO) support prior to the procedure, subsequently died from causes unrelated to the thrombectomy intervention. In this limited case series, the Penumbra Indigo Lightning System demonstrated feasibility for transcatheter thrombus removal in pediatric patients across a spectrum of CHD. Given the limited number of available catheter systems in this population, this approach may be considered as a first‐line or adjunct therapy in select patients when conventional medical management is insufficient or contraindicated. Further prospective studies are needed to define optimal patient selection, procedural techniques, and post‐procedural management.This publication has 18 references indexed in Scilit:
- Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary HypertensionJACC, 2025
- A novel approach to thrombectomy and catheter directed tissue-type plasminogen activator in a toddler post-fontanProgress in Pediatric Cardiology, 2024
- Percutaneous treatment of symptomatic deep vein thrombosis in adolescents using large-bore thrombectomy systemsPediatric Radiology, 2023
- Thromboprophylaxis in Patients With Fontan CirculationJACC, 2023
- Indigo Aspiration System for Treatment of Pulmonary EmbolismJACC: Cardiovascular Interventions, 2021
- Removal of Caval and Right Atrial Thrombi and Masses Using the AngioVac Device: Initial Operative ExperienceJournal of Vascular and Interventional Radiology, 2016
- Efficacy and safety of catheter‐based rheolytic and aspiration thrombectomy in childrenCatheterization and Cardiovascular Interventions, 2016
- Transcatheter pulmonary embolectomy after fontanCatheterization and Cardiovascular Interventions, 2015
- Thrombotic Complications and Thromboprophylaxis Across All Three Stages of Single Ventricle Heart PalliationThe Journal of Pediatrics, 2012
- Thromboembolism and the Role of Anticoagulation in the Fontan PatientPediatric Cardiology, 2007